ACP5 and osteoporosis: In our study, SRT2104 significantly promoted MC3T3-E1 cell osteogenesis as evidenced by ALP staining and inhibited the formation of TRAP-positive multinucleate cells in vitro (Figure 2), indicating its potential for osteoporosis treatment.